UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051556
Receipt number R000058822
Scientific Title Machine Learning Approach to Predict Tracheal Necrosis after Total Pharyngolaryngectomy and Free Jejunal Transfer
Date of disclosure of the study information 2023/07/08
Last modified on 2023/07/08 22:01:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Machine Learning Approach to Predict Tracheal Necrosis after Total Pharyngolaryngectomy and Free Jejunal Transfer

Acronym

Machine Learning Approach to Predict Tracheal Necrosis after Total Pharyngolaryngectomy and Free Jejunal Transfer

Scientific Title

Machine Learning Approach to Predict Tracheal Necrosis after Total Pharyngolaryngectomy and Free Jejunal Transfer

Scientific Title:Acronym

Machine Learning Approach to Predict Tracheal Necrosis after Total Pharyngolaryngectomy and Free Jejunal Transfer

Region

Japan


Condition

Condition

All patients underwent TPL and FJT for biopsy-proven squamous cell carcinoma (SCC) at our institution from April 2010 to April 2023 were included. Exclusion criteria were: (1) patients underwent TPL and FJT for non-SCC, (2) patients underwent TPL and FJT in conjunction with total esophagectomy and (3) patients with prior history of total esophagectomy.

Classification by specialty

Plastic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The primary aim of this study is to identify risk factors for tracheal necrosis after TPL and FJT without total esophagectomy.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary endpoint was the incidence of tracheal necrosis.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

200 years-old >=

Gender

Male and Female

Key inclusion criteria

All patients underwent TPL and FJT for biopsy-proven squamous cell carcinoma (SCC) at our institution from April 2010 to April 2023 were included.

Key exclusion criteria

Exclusion criteria were: (1) patients underwent TPL and FJT for non-SCC, (2) patients underwent TPL and FJT in conjunction with total esophagectomy and (3) patients with prior history of total esophagectomy.

Target sample size

395


Research contact person

Name of lead principal investigator

1st name Takeaki
Middle name
Last name Hidaka

Organization

National Cancer Center Hospital East, Kashiwa, Japan

Division name

Department of Plastic and Reconstructive Surgery

Zip code

277-8577

Address

6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

TEL

+81-4-7133-1111

Email

tahidaka1986@gmail.com


Public contact

Name of contact person

1st name Takeaki
Middle name
Last name Hidaka

Organization

National Cancer Center Hospital East, Kashiwa, Japan

Division name

Department of Plastic and Reconstructive Surgery

Zip code

277-8577

Address

6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

TEL

81471331111

Homepage URL


Email

tahidaka1986@gmail.com


Sponsor or person

Institute

Department of Plastic and Reconstructive Surgery,
National Cancer Center Hospital East
6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Institute

Department

Personal name



Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Hospital East

Address

6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Tel

+81-4-7133-1111

Email

tahidaka1986@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

395

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 04 Month 01 Day

Date of IRB

2017 Year 04 Month 01 Day

Anticipated trial start date

2010 Year 04 Month 02 Day

Last follow-up date

2023 Year 07 Month 08 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Primary endpoint was the incidence of tracheal necrosis. Tracheal necrosis was defined as the necrotic lesion of the cartilage or the pars membranacea of more than one tracheal ring1 developed during the postoperative hospitalization period and required any medical treatments including ointment application.
Tracheostoma stenosis is one of the most important sequelae of tracheal necrosis. We define tracheostoma stenosis as the condition requiring tracheal stenting with a T-tube within postoperative six months, and investigated its incidence in the patients developed tracheal necrosis.
As treatment of tracheal necrosis can be time-consuming, hospitalization period was compared between the groups with and without tracheal necrosis.


Management information

Registered date

2023 Year 07 Month 08 Day

Last modified on

2023 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058822